ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for CPRX

Stock NameCatalyst Pharmaceuticals Inc
TickerCPRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS14888U1016
LEI5299004O0R5XXLA5H544

Show aggregate CPRX holdings

News associated with CPRX

Mutual of America Capital Management LLC Sells 657 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Mutual of America Capital Management LLC lessened its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 3.9% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,327 shares of the biopharmaceutical company’s stock after selling 657 shares during the quarter. Mutual of America […] - 2025-08-13 05:45:09
Maryland State Retirement & Pension System Sells 4,969 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Maryland State Retirement & Pension System lowered its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 13.2% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 32,706 shares of the biopharmaceutical company’s stock after selling 4,969 shares during the period. Maryland State Retirement & […] - 2025-08-13 05:06:50
Wall Street Zen Downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to Hold
Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) was downgraded by Wall Street Zen from a “strong-buy” rating to a “hold” rating in a research report issued on Saturday. Separately, Cantor Fitzgerald raised shares of Catalyst Pharmaceuticals to a “strong-buy” rating in a research report on Thursday, June 5th. One investment analyst has rated the stock […] - 2025-08-11 05:44:53
Zurcher Kantonalbank Zurich Cantonalbank Has $774,000 Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 11.3% in the first quarter, Holdings Channel.com reports. The firm owned 31,897 shares of the biopharmaceutical company’s stock after acquiring an additional 3,244 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Catalyst Pharmaceuticals were worth […] - 2025-08-06 06:08:49
Federated Hermes Inc. Decreases Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Federated Hermes Inc. decreased its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 57.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 74,484 shares of the biopharmaceutical company’s stock after selling 99,906 shares during the quarter. Federated Hermes Inc. owned […] - 2025-08-06 05:12:59
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives $32.83 Consensus Target Price from Brokerages
Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) have been given an average recommendation of “Buy” by the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average […] - 2025-07-25 05:48:50
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Holdings Lifted by New York State Common Retirement Fund
New York State Common Retirement Fund grew its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 155.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 92,001 shares of the biopharmaceutical company’s stock after purchasing an additional 55,968 shares during […] - 2025-07-24 04:40:46
Alps Advisors Inc. Reduces Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Alps Advisors Inc. lessened its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 3.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,476 shares of the biopharmaceutical company’s stock after selling 633 shares during the […] - 2025-07-15 06:26:34
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by Oregon Public Employees Retirement Fund
Oregon Public Employees Retirement Fund lessened its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 25,639 shares of the biopharmaceutical company’s stock after selling 705 shares during the period. Oregon Public Employees Retirement Fund’s holdings in […] - 2025-07-08 05:24:52
Wealth Enhancement Advisory Services LLC Grows Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Wealth Enhancement Advisory Services LLC increased its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 65.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 35,334 shares of the biopharmaceutical company’s stock after acquiring an additional 13,915 shares during the quarter. Wealth […] - 2025-07-03 04:26:50
Oppenheimer & Co. Inc. Lowers Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Oppenheimer & Co. Inc. decreased its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 5.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 98,746 shares of the biopharmaceutical company’s stock after selling 5,741 shares during the period. Oppenheimer & […] - 2025-06-27 05:48:55
XML Financial LLC Sells 20,000 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
XML Financial LLC cut its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 66.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,000 shares of the biopharmaceutical company’s stock after selling 20,000 shares during the […] - 2025-06-25 05:35:06
Sound Income Strategies LLC Takes Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Sound Income Strategies LLC acquired a new stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm acquired 2,654 shares of the biopharmaceutical company’s stock, valued at approximately $64,000. Other hedge funds and other institutional investors have also recently made changes to their positions in the […] - 2025-06-17 05:26:52
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Holdings Increased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 11.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 263,905 shares of the biopharmaceutical company’s […] - 2025-06-03 05:13:09
Mackenzie Financial Corp Grows Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Mackenzie Financial Corp boosted its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 132.9% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 34,531 shares of the biopharmaceutical company’s stock after buying an additional 19,705 shares during the quarter. Mackenzie Financial Corp’s holdings in Catalyst Pharmaceuticals were worth $721,000 at […] - 2025-06-02 05:49:04
Tidal Investments LLC Reduces Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Tidal Investments LLC trimmed its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 4.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,141 shares of the biopharmaceutical company’s stock after selling 1,905 shares during the period. Tidal Investments […] - 2025-05-27 05:22:56
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Raises Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 3.4% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 68,252 shares of the biopharmaceutical company’s stock after buying an additional 2,252 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Catalyst Pharmaceuticals […] - 2025-05-25 07:56:51
BNP Paribas Financial Markets Has $2.67 Million Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
BNP Paribas Financial Markets cut its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 16.7% during the 4th quarter, Holdings Channel reports. The firm owned 127,679 shares of the biopharmaceutical company’s stock after selling 25,571 shares during the quarter. BNP Paribas Financial Markets’ holdings in Catalyst Pharmaceuticals were worth $2,665,000 as […] - 2025-05-16 05:24:51
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Holdings Lowered by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company reduced its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 60,366 shares of the biopharmaceutical company’s stock after selling 1,444 shares during the quarter. The Manufacturers […] - 2025-05-13 05:26:56
Envestnet Asset Management Inc. Acquires 39,836 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Envestnet Asset Management Inc. lifted its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 162.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,395 shares of the biopharmaceutical company’s stock after purchasing an additional 39,836 shares during the quarter. Envestnet […] - 2025-04-30 04:27:02
Barclays PLC Sells 4,035 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Barclays PLC lessened its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 1.6% in the 4th quarter, Holdings Channel reports. The firm owned 244,423 shares of the biopharmaceutical company’s stock after selling 4,035 shares during the period. Barclays PLC’s holdings in Catalyst Pharmaceuticals were worth $5,101,000 at the end of the most recent […] - 2025-04-27 05:54:51
Raymond James Financial Inc. Invests $6.89 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Raymond James Financial Inc. acquired a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 329,980 shares of the biopharmaceutical company’s stock, valued at approximately $6,887,000. Several other hedge funds have […] - 2025-04-24 04:41:07
Summit Investment Advisors Inc. Boosts Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Summit Investment Advisors Inc. grew its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 5.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 11,696 shares of the biopharmaceutical company’s stock after buying an additional 580 shares during the period. Summit Investment Advisors Inc.’s holdings in Catalyst Pharmaceuticals were worth […] - 2025-04-22 05:47:00
Cerity Partners LLC Has $548,000 Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Cerity Partners LLC decreased its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 7.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 26,482 shares of the biopharmaceutical company’s stock after selling 2,251 shares during the period. Cerity Partners LLC’s holdings in Catalyst Pharmaceuticals were worth $548,000 as of its most […] - 2025-04-22 04:50:54
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by Russell Investments Group Ltd.
Russell Investments Group Ltd. increased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 1.4% during the fourth quarter, Holdings Channel reports. The fund owned 176,259 shares of the biopharmaceutical company’s stock after purchasing an additional 2,471 shares during the quarter. Russell Investments Group Ltd.’s holdings in Catalyst Pharmaceuticals were worth $3,679,000 as […] - 2025-04-16 05:06:59
Analysts Set Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Price Target at $32.29
Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) have earned a consensus rating of “Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target […] - 2025-04-14 03:01:01
Corebridge Financial Inc. Cuts Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Corebridge Financial Inc. lessened its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 7.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 59,539 shares of the biopharmaceutical company’s stock after selling 4,627 shares during the period. Corebridge Financial Inc.’s holdings in […] - 2025-04-04 05:10:55
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Holdings Boosted by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC raised its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 133.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 39,331 shares of the biopharmaceutical company’s stock after acquiring an additional 22,455 shares during the period. […] - 2025-04-03 04:20:49
KLP Kapitalforvaltning AS Invests $772,000 in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
KLP Kapitalforvaltning AS bought a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 37,000 shares of the biopharmaceutical company’s stock, valued at approximately $772,000. Several other hedge funds and other institutional […] - 2025-04-01 05:17:01
Cibc World Markets Corp Acquires New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Cibc World Markets Corp bought a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund bought 10,463 shares of the biopharmaceutical company’s stock, valued at approximately $218,000. A number of other hedge funds have also bought and sold shares of the stock. Steward Partners […] - 2025-03-27 06:54:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CPRX holdings

DateNumber of CPRX Shares HeldBase Market Value of CPRX SharesLocal Market Value of CPRX SharesChange in CPRX Shares HeldChange in CPRX Base ValueCurrent Price per CPRX Share HeldPrevious Price per CPRX Share Held
2025-12-11 (Thursday)70,365USD 1,614,173CPRX holding increased by 9851USD 1,614,1730USD 9,851 USD 22.94 USD 22.8
2025-12-10 (Wednesday)70,365USD 1,604,322CPRX holding increased by 17591USD 1,604,3220USD 17,591 USD 22.8 USD 22.55
2025-12-09 (Tuesday)70,365USD 1,586,731CPRX holding decreased by -42922USD 1,586,7310USD -42,922 USD 22.55 USD 23.16
2025-12-08 (Monday)70,365USD 1,629,653CPRX holding decreased by -26035USD 1,629,6530USD -26,035 USD 23.16 USD 23.53
2025-12-05 (Friday)70,365USD 1,655,688CPRX holding increased by 31664USD 1,655,6880USD 31,664 USD 23.53 USD 23.08
2025-12-04 (Thursday)70,365USD 1,624,024CPRX holding decreased by -1408USD 1,624,0240USD -1,408 USD 23.08 USD 23.1
2025-12-03 (Wednesday)70,365CPRX holding increased by 4364USD 1,625,432CPRX holding increased by 132489USD 1,625,4324,364USD 132,489 USD 23.1 USD 22.62
2025-12-02 (Tuesday)66,001CPRX holding increased by 456USD 1,492,943CPRX holding increased by 5727USD 1,492,943456USD 5,727 USD 22.62 USD 22.69
2025-12-01 (Monday)65,545USD 1,487,216CPRX holding decreased by -47192USD 1,487,2160USD -47,192 USD 22.69 USD 23.41
2025-11-28 (Friday)65,545USD 1,534,408CPRX holding decreased by -1311USD 1,534,4080USD -1,311 USD 23.41 USD 23.43
2025-11-27 (Thursday)65,545USD 1,535,719USD 1,535,7190USD 0 USD 23.43 USD 23.43
2025-11-26 (Wednesday)65,545USD 1,535,719CPRX holding decreased by -10488USD 1,535,7190USD -10,488 USD 23.43 USD 23.59
2025-11-25 (Tuesday)65,545CPRX holding decreased by -684USD 1,546,207CPRX holding decreased by -10837USD 1,546,207-684USD -10,837 USD 23.59 USD 23.51
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CPRX by Blackrock for IE00B3VWM098

Show aggregate share trades of CPRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03BUY4,36423.24022.660 22.718USD 99,141 22.44
2025-12-02BUY45622.93022.420 22.471USD 10,247 22.44
2025-11-25SELL-68423.92023.530 23.569USD -16,121 22.42 Loss of -787 on sale
2025-11-24SELL-68423.58023.190 23.229USD -15,889 22.41 Loss of -558 on sale
2025-11-17SELL-2,50823.21022.404 22.484USD -56,391 22.41 Loss of -199 on sale
2025-11-12SELL-22823.18522.545 22.609USD -5,155 22.40 Loss of -49 on sale
2025-11-06SELL-22822.84020.890 21.085USD -4,807 22.41 Profit of 302 on sale
2025-11-05SELL-2,28021.83020.960 21.047USD -47,987 22.41 Profit of 3,118 on sale
2025-11-04SELL-45621.52021.060 21.106USD -9,624 22.42 Profit of 599 on sale
2025-11-03SELL-45621.74020.950 21.029USD -9,589 22.43 Profit of 637 on sale
2025-10-28BUY68421.36021.490 21.477USD 14,690 22.45
2025-10-24SELL-22820.96021.150 21.131USD -4,818 22.47 Profit of 304 on sale
2025-10-15BUY1,36821.26021.290 21.287USD 29,121 22.53
2025-10-02BUY22820.84021.050 21.029USD 4,795 22.55
2025-09-30BUY45619.70019.920 19.898USD 9,073 22.57
2025-09-11BUY91220.25020.310 20.304USD 18,517 22.66
2025-08-21SELL-22820.56020.620 20.614USD -4,700 22.67 Profit of 469 on sale
2025-07-31BUY68421.33021.710 21.672USD 14,824 22.69
2025-06-30SELL-45621.70022.070 22.033USD -10,047 22.88 Profit of 385 on sale
2025-06-25SELL-22821.54022.110 22.053USD -5,028 22.90 Profit of 193 on sale
2025-06-20SELL-45622.48023.110 23.047USD -10,509 22.92 Loss of -60 on sale
2025-05-23BUY22824.49024.550 24.544USD 5,596 22.64
2025-05-19SELL-22824.63024.680 24.675USD -5,626 22.57 Loss of -479 on sale
2025-05-15SELL-68423.78023.980 23.960USD -16,389 22.55 Loss of -966 on sale
2025-05-12SELL-22823.83024.080 24.055USD -5,485 22.52 Loss of -350 on sale
2025-05-09SELL-22823.37023.700 23.667USD -5,396 22.51 Loss of -263 on sale
2025-04-30SELL-22824.29024.610 24.578USD -5,604 22.42 Loss of -492 on sale
2025-04-24SELL-45623.19023.400 23.379USD -10,661 22.37 Loss of -459 on sale
2025-04-22BUY3,70722.60022.930 22.897USD 84,879 22.36
2025-04-17SELL-21622.52022.670 22.655USD -4,893 22.36 Loss of -63 on sale
2025-04-15SELL-64823.23023.270 23.266USD -15,076 22.36 Loss of -590 on sale
2025-04-14SELL-64822.80022.890 22.881USD -14,827 22.35 Loss of -343 on sale
2025-04-09SELL-86422.74023.070 23.037USD -19,904 22.36 Loss of -585 on sale
2025-04-07SELL-1,51221.81022.930 22.818USD -34,501 22.38 Loss of -666 on sale
2025-04-04SELL-2,16023.07024.270 24.150USD -52,164 22.37 Loss of -3,846 on sale
2025-03-31BUY21624.25024.500 24.475USD 5,287 22.30
2025-03-19SELL-43222.60022.740 22.726USD -9,818 22.07 Loss of -285 on sale
2025-03-14SELL-1,29621.02021.190 21.173USD -27,440 22.08 Profit of 1,182 on sale
2025-03-13SELL-43420.87021.250 21.212USD -9,206 22.10 Profit of 386 on sale
2025-03-12SELL-7,37821.20021.420 21.398USD -157,874 22.11 Profit of 5,288 on sale
2025-03-07SELL-43421.96022.240 22.212USD -9,640 22.16 Loss of -24 on sale
2025-03-06SELL-65121.67021.960 21.931USD -14,277 22.16 Profit of 151 on sale
2025-03-04BUY5,25522.10022.540 22.496USD 118,216 22.17
2025-03-03SELL-20222.32023.390 23.283USD -4,703 22.17 Loss of -226 on sale
2025-02-28BUY63,15122.89022.900 22.899USD 1,446,095 22.15
2025-02-26SELL-3220.58020.960 20.922USD -670 22.19 Profit of 41 on sale
2025-02-25SELL-9620.80021.510 21.439USD -2,058 22.21 Profit of 74 on sale
2025-02-18BUY16022.93023.590 23.524USD 3,764 22.22
2025-02-13BUY3223.26023.260 23.260USD 744 22.16
2025-02-12BUY3222.70023.030 22.997USD 736 22.15
2025-02-11BUY9622.58022.740 22.724USD 2,182 22.14
2025-02-06BUY28823.06023.640 23.582USD 6,792 22.08
2025-01-27BUY3222.70023.140 23.096USD 739 21.88
2024-12-30BUY16021.07021.360 21.331USD 3,413 21.87
2024-12-06BUY12822.02022.080 22.074USD 2,825 21.86
2024-12-05BUY3221.70021.920 21.898USD 701 21.87
2024-12-04BUY16021.96022.060 22.050USD 3,528 21.87
2024-11-29BUY16022.07022.630 22.574USD 3,612 21.84
2024-11-27BUY12822.34023.020 22.952USD 2,938 21.80
2024-11-26BUY3221.93022.020 22.011USD 704 21.79
2024-11-21BUY16021.12021.210 21.201USD 3,392 21.87
2024-11-20BUY9621.15021.630 21.582USD 2,072 21.91
2024-11-18BUY38420.82021.190 21.153USD 8,123 22.01
2024-11-12BUY25623.04023.730 23.661USD 6,057 21.94
2024-11-08BUY16023.93024.270 24.236USD 3,878 21.80
2024-11-07BUY48023.25024.210 24.114USD 11,575 21.69
2024-11-06BUY6422.71023.120 23.079USD 1,477 21.61
2024-10-31BUY3221.80021.950 21.935USD 702 21.49
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CPRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19276,99817,064585,94647.3%
2025-09-18273,5426654,96541.8%
2025-09-17145,783207420,08534.7%
2025-09-16345,62336799,71543.2%
2025-09-15359,35011711,69850.5%
2025-09-12263,666500503,80152.3%
2025-09-11397,6281644,18361.7%
2025-09-10483,7541,022823,39458.8%
2025-09-09423,631452684,24161.9%
2025-09-08630,823271,059,11259.6%
2025-09-05600,6830965,91562.2%
2025-09-04356,64415,0541,095,12732.6%
2025-09-03440,81917,0261,088,95640.5%
2025-09-02227,6890675,52733.7%
2025-08-29168,8910266,91363.3%
2025-08-28212,4410580,55836.6%
2025-08-27227,336741631,54836.0%
2025-08-26272,7866696,06639.2%
2025-08-25485,95112909,18253.4%
2025-08-22129,0200392,21532.9%
2025-08-21126,74098346,77336.5%
2025-08-2089,4420222,18140.3%
2025-08-19123,2810333,82336.9%
2025-08-18128,299365525,06624.4%
2025-08-15104,0840467,70122.3%
2025-08-14121,554798465,52626.1%
2025-08-13109,173498355,50930.7%
2025-08-12115,1021,009365,78431.5%
2025-08-11221,7951,832606,25036.6%
2025-08-08336,25418,147879,54738.2%
2025-08-07787,97072,7541,873,82642.1%
2025-08-06468,05512661,20670.8%
2025-08-05320,4361,415590,58954.3%
2025-08-04146,2460335,58843.6%
2025-08-01159,7170320,35049.9%
2025-07-31200,956758314,18064.0%
2025-07-30252,238300439,84957.3%
2025-07-29343,373514567,80060.5%
2025-07-28331,906578493,04667.3%
2025-07-25187,76536341,48655.0%
2025-07-24162,8120272,74859.7%
2025-07-23369,6462,352683,18054.1%
2025-07-22270,4622,750511,95452.8%
2025-07-21232,6920404,21457.6%
2025-07-18283,718450390,36872.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy